XML 407 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
BUSINESS ACQUISITIONS - Additional Information (Details)
$ in Millions
12 Months Ended
Dec. 30, 2024
USD ($)
Oct. 13, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 16, 2024
USD ($)
Aug. 23, 2024
USD ($)
Aug. 23, 2024
CAD ($)
Jun. 10, 2024
USD ($)
Feb. 12, 2024
USD ($)
Jun. 20, 2023
USD ($)
Apr. 17, 2023
USD ($)
Feb. 01, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2024
USD ($)
Business Acquisition [Line Items]                              
Total consideration                       $ 2,200,000,000 $ 699,000,000 $ 162,000,000  
Contingent consideration                         88,000,000 18,000,000 $ 6,000,000
Business acquisitions, net of cash acquired                       2,164,000,000 611,000,000 144,000,000  
Goodwill acquired during the year                       1,146,000,000 511,000,000 121,000,000  
Goodwill deductible for tax purposes                       862,000,000 244,000,000 103,000,000  
Cash consideration                       2,214,000,000 612,000,000 148,000,000  
Net revenues                       9,872,000,000 9,252,000,000 9,883,000,000  
Goodwill                       8,856,000,000 7,733,000,000 7,220,000,000  
Cash acquired from acquisition                       $ 50,000,000 1,000,000 4,000,000  
Minimum                              
Business Acquisition [Line Items]                              
Finite-lived intangible asset, useful life                       5 years      
Maximum                              
Business Acquisition [Line Items]                              
Finite-lived intangible asset, useful life                       25 years      
Customer - related                              
Business Acquisition [Line Items]                              
Finite-lived intangibles                         63,000,000 $ 45,000,000  
Finite-lived intangible asset, useful life                       18 years      
Trade names                              
Business Acquisition [Line Items]                              
Finite-lived intangible asset, useful life                       15 years      
Non-competition agreements                              
Business Acquisition [Line Items]                              
Finite-lived intangible asset, useful life                       5 years      
Technology-based intangible assets                              
Business Acquisition [Line Items]                              
Finite-lived intangibles                         $ 145,000,000    
Finite-lived intangible asset, useful life                       15 years      
Current Year Acquisitions, Prepaids in Previous Year                              
Business Acquisition [Line Items]                              
Business acquisitions, net of cash acquired                       $ (30,000,000)      
Current Year Acquisitions, Prepaids in Previous Year                              
Business Acquisition [Line Items]                              
Total consideration                       30,000,000      
Lenco Diagnostics Laboratories, Inc.                              
Business Acquisition [Line Items]                              
Cash consideration               $ 111,000,000              
PathAI Diagnostics                              
Business Acquisition [Line Items]                              
Cash consideration             $ 100,000,000                
LifeLabs                              
Business Acquisition [Line Items]                              
Cash consideration         $ 1,000,000,000 $ 1,350                  
Net revenues                       241,000,000      
Goodwill                       303,000,000      
Operating lease right-of-use assets                       65,000,000      
Property, plant and equipment                       250,000,000      
Finance lease liabilities (recorded in long-term debt)                       $ 0      
LifeLabs | Customer - related | Discount rate | Valuation, Income Approach | Minimum                              
Business Acquisition [Line Items]                              
Measurement input                       0.130      
LifeLabs | Customer - related | Discount rate | Valuation, Income Approach | Maximum                              
Business Acquisition [Line Items]                              
Measurement input                       0.140      
LifeLabs | Trade names | Discount rate | Valuation, Royalty Method                              
Business Acquisition [Line Items]                              
Measurement input                       0.120      
Allina Health                              
Business Acquisition [Line Items]                              
Cash consideration       $ 230,000,000                      
Goodwill                       $ 175,000,000      
Operating lease right-of-use assets                       0      
Property, plant and equipment                       0      
Finance lease liabilities (recorded in long-term debt)                       0      
Laboratory Business of Three Physician Groups in New York                              
Business Acquisition [Line Items]                              
Cash consideration     $ 300,000,000                        
Goodwill                       243,000,000      
Operating lease right-of-use assets                       0      
Property, plant and equipment                       0      
Finance lease liabilities (recorded in long-term debt)                       0      
OhioHealth                              
Business Acquisition [Line Items]                              
Cash consideration   $ 200,000,000                          
Goodwill                       146,000,000      
Operating lease right-of-use assets                       0      
Property, plant and equipment                       0      
Finance lease liabilities (recorded in long-term debt)                       0      
Outreach Laboratory Services Business of University Hospitals                              
Business Acquisition [Line Items]                              
Cash consideration $ 183,000,000                            
Goodwill                       125,000,000      
Operating lease right-of-use assets                       0      
Property, plant and equipment                       0      
Finance lease liabilities (recorded in long-term debt)                       $ 0      
New York-Presbyterian                              
Business Acquisition [Line Items]                              
Goodwill deductible for tax purposes                   $ 222,000,000          
Cash consideration                   275,000,000          
Goodwill                   222,000,000          
New York-Presbyterian | Customer - related                              
Business Acquisition [Line Items]                              
Finite-lived intangibles                   $ 53,000,000          
Finite-lived intangible asset, useful life                   15 years          
Haystack Oncology, Inc.                              
Business Acquisition [Line Items]                              
Total consideration                 $ 392,000,000            
Contingent consideration                 88,000,000            
Goodwill deductible for tax purposes                 0            
Cash consideration                 304,000,000            
Goodwill                 267,000,000            
Cash acquired from acquisition                 1,000,000            
Deferred tax liabilities                 23,000,000            
Operating lease right-of-use assets                 8,000,000            
Property, plant and equipment                 3,000,000            
Operating lease liabilities                 8,000,000            
Haystack Oncology, Inc. | Discount rate                              
Business Acquisition [Line Items]                              
Measurement input                       0.105      
Haystack Oncology, Inc. | Technology-based intangible assets                              
Business Acquisition [Line Items]                              
Finite-lived intangibles                 $ 145,000,000            
Finite-lived intangible asset, useful life                 15 years            
Haystack Oncology, Inc. | Additional, Reimbursement Coverage                              
Business Acquisition [Line Items]                              
Contingent consideration arrangements, range of outcomes, value, high                 $ 50,000,000            
Pack Health, LLC                              
Business Acquisition [Line Items]                              
Total consideration                     $ 123,000,000        
Contingent consideration                     18,000,000        
Business acquisitions, net of cash acquired                     105,000,000        
Goodwill deductible for tax purposes                     78,000,000        
Finite-lived intangibles                     30,000,000        
Goodwill                     96,000,000        
Cash acquired from acquisition                     4,000,000        
Operating lease right-of-use assets                     5,000,000        
Operating lease liabilities                     5,000,000        
Working capital                     $ (3,000,000)        
Pack Health, LLC | Customer - related                              
Business Acquisition [Line Items]                              
Finite-lived intangible asset, useful life                     15 years